Memphasys Ltd (AU:MEM) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Memphasys Limited (ASX: MEM), a leader in reproductive biotechnology, announced the successful outcomes of its 2024 Annual General Meeting. Key resolutions, including the election and re-election of directors and the approval of strategic mandates, were carried with strong support. This marks a positive step for the company as it continues to innovate in biotechnology applications.
For further insights into AU:MEM stock, check out TipRanks’ Stock Analysis page.
